NSE filing, NSE: MADHAVBAUG. Summary written from the filing by ALFA Finder's alert engine.
Vaidya Sane Ayurved Laboratories Ltd: key numbers
- Share price
- ₹150.00
- Market cap
- ₹157.7 Cr
- Revenue (annual)
- ₹106.9 Cr
- Net profit (annual)
- ₹8.99 Cr
- P/E (TTM)
- 17.6×Sector 33.8×
- Promoter holding
- 66.34%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vaidya Sane Ayurved Laboratories Ltd
All →Vaidya Sane Ayurved Laboratories Other Announcement
The Company has filed an undertaking confirming that Corporate Governance provisions under Regulation 27 of SEBI (LODR) are not applicable for the current quarter.
Vaidya Sane Ayurved Laboratories Annual General Meeting
Vaidya Sane Ayurved Laboratories held its 27th AGM on September 30, 2026. Shareholders considered the adoption of financial results, auditor re-appointments, and approval of ESOP 2026.
Vaidya Sane Ayurved Laboratories Annual General Meeting
Vaidya Sane Ayurved Laboratories will hold its 27th Annual General Meeting on September 30, 2026, via video conferencing. The company also filed its FY 2025-26 Annual Report.
Vaidya Sane Ayurved Laboratories Board Meeting Outcome
The company's board approved the 27th AGM details, director/auditor re-appointments, an increase in MD remuneration, and the introduction of the 'VSALL - ESOP 2026' scheme.
Vaidya Sane Ayurved Laboratories Other Announcement
Vaidya Sane Ayurved Laboratories filed a statement of deviation or variation in fund utilization pursuant to Regulation 32(1) for the quarter ended June 30, 2026.
Vaidya Sane Ayurved Laboratories Management Change
Vaidya Sane Ayurved Laboratories announced the resignation of Rohit Madhav Sane as CEO. Mr. D. Ramakrishna has been appointed as the new CEO and KMP.
Other business update announcements
All →Alkem Laboratories Business Update
Alkem informed the exchange that US FDA completed inspection of its Mandva API facility with no Form 483 observations. The clean result confirms regulatory compliance.
Libas Consumer Products Business Update
Libas announced a 25% discount voucher for all registered shareholders, valid November 2026 to October 2027. Shareholders claim it via email with demat details.
GAIL (India) Business Update
GAIL revises Durgapur-Haldia and Dhamra-Haldia pipeline completion to March 2027 due to unavailability of hindrance-free fronts. No additional investment is required for either section.
Kirloskar Industries Business Update
Kirloskar Industries forwarded Q1 FY27 unaudited results of subsidiary KFIL to exchanges. The filing discloses revenue, profit, and key financial ratios for the September quarter.
OneSource Specialty Pharma Business Update
OneSource received a USFDA EIR with VAI classification for its Bengaluru SPD facility. This marks completion of the June 2026 inspection with no monetary penalty.
GP Eco Solutions India Business Update
GP Eco Solutions shared a factory showcase video of subsidiary Invergy India's first-phase manufacturing facility. The video highlights production capabilities, infrastructure, and product portfolio.